mifobate (SR 202)

Subscribe to Selected New Research on mifobate

2 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: has antiatherosclerotic properties

Also Known As:

SR 202; SR-202; (4-chlorophenyl)(dimethoxyphosphinyl)methylphosphoric acid dimethyl ester; Clenicor; dimethyl alpha-(dimethoxyphosphinyl)-4-chlorobenzyl phosphate

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organophosphorus Compounds: 126

mifobate: 2

Related Diseases

1.	Insulin Resistance 11/01/2002 - "In vivo, decreasing PPARgamma activity, either by treatment with SR-202 or by invalidation of one allele of the PPARgamma gene, leads to a reduction of both high fat diet-induced adipocyte hypertrophy and insulin resistance" 04/01/2003 - "Feeding mice with a high-fat diet induced insulin resistance measured as increased plasma levels of glucose, insulin and free fatty acids, and SR-202 protected against these changes" Get all the results and reference details, order at left...
2.	Obesity 11/01/2002 - "Because it yields both antiobesity and antidiabetic effects, SR-202 may be a lead for new compounds to be used in the treatment of obesity and type 2 diabetes." Get all the results and reference details, order at left...
3.	Hypertrophy 11/01/2002 - "In vivo, decreasing PPARgamma activity, either by treatment with SR-202 or by invalidation of one allele of the PPARgamma gene, leads to a reduction of both high fat diet-induced adipocyte hypertrophy and insulin resistance" Get all the results and reference details, order at left...
3 Diseases and 2 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	PPAR gamma
2.	Insulin (Novolin)
3.	Glucose (Dextrose)
4.	Nonesterified Fatty Acids (NEFA)
4 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>